Literature DB >> 15103281

Contrast-enhanced US of hepatocellular carcinoma.

Mirko D'Onofrio1, Umberto Rozzanigo, Sabrina Caffarri, Andrea Zogno, Carlo Procacci.   

Abstract

PURPOSE: To evaluate the capabilities of contrast-enhanced ultrasound (CEUS) in the characterization of hepatocarcinoma (HCC) in terms of accuracy as compared to spiral CT and diagnostic gain as compared to conventional and Doppler US.
MATERIALS AND METHODS: Forty-three patients with viral hepatopathy or cirrhosis diagnosed with HCC (6 histologically and 37 cytologically proven) were retrospectively studied. Between January 2002 and May 2003, all patients were evaluated with CEUS after detection of at least one suspicious nodule on US. CEUS features of HCCs were retrospectively compared with those on conventional and Doppler US, and spiral CT.
RESULTS: HCCs varied between 1.2 cm and 18 cm in diameter; 14/43 were small' (< or = 2 cm). In 18/43 patients, HCC was multifocal. Doppler US revealed 24/43 hypervascular nodules. On CEUS, 37/43 (86%) showed contrast enhancement in the arterial phase, 13/37 (35%) with negative colour and power Doppler US examination; in 6/37 (16%) contrast enhancement in the arterial phase was not visible on spiral CT. On CEUS, 6/43 hypovascular HCCs were characterized as malignant in the sinusoidal phase. On CEUS, the sinusoidal phase revealed additional nodules not visible on baseline US in 3/18 multifocal HCCs.
CONCLUSIONS: CEUS diagnosis of HCC in cirrhotic liver is possible with a combination of the arterial phase, which shows tumoral hypervascularity in the microcirculation, and the sinusoidal phase, which allows to confirm the malignancy of the nodule.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15103281

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  6 in total

1.  Differentiation of focal liver lesions using three-dimensional ultrasonography: retrospective and prospective studies.

Authors:  Wen Luo; Kazushi Numata; Manabu Morimoto; Akito Nozaki; Michio Ueda; Masaaki Kondo; Satoshi Morita; Katsuaki Tanaka
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

2.  Malignant focal liver lesions at contrast-enhanced ultrasonography and magnetic resonance with hepatospecific contrast agent.

Authors:  M D'Onofrio; S Crosara; R De Robertis; S Canestrini; V Cantisani; G Morana; R Pozzi Mucelli
Journal:  Ultrasound       Date:  2013-12-13

3.  Standardize and compare contrast-enhanced ultrasonographic digital images obtained with different technologies: how to overcome the subjectivity.

Authors:  Mirko D'Onofrio; Niccolò Faccioli; Roberto Malagò; Giulia Zamboni; Roberto Pozzi Mucelli
Journal:  J Digit Imaging       Date:  2007-09       Impact factor: 4.056

4.  Tumor vessel compression hinders perfusion of ultrasonographic contrast agents.

Authors:  Mirco Galiè; Mirko D'Onofrio; Maura Montani; Augusto Amici; Laura Calderan; Pasquina Marzola; Donatella Benati; Flavia Merigo; Cristina Marchini; Andrea Sbarbati
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

Review 5.  Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Mirella Fraquelli; Tin Nadarevic; Agostino Colli; Cristina Manzotti; Vanja Giljaca; Damir Miletic; Davor Štimac; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2022-09-02

6.  Diagnostic value of hepatocellular nodule vascularity after microbubble injection for characterizing malignancy in patients with cirrhosis.

Authors:  Emilio Quaia; Mirko D'Onofrio; Paolo Cabassa; Francesca Vecchiato; Sabrina Caffarri; Frida Pittiani; Knut M Wittkowski; Maria Assunta Cova
Journal:  AJR Am J Roentgenol       Date:  2007-12       Impact factor: 3.959

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.